Join to access to all OVN content. Join for Free
Movement as Medicine: The Science Reshaping Oncology
City of Hope Academic Research movement exercise holistic

Movement as Medicine: The Science Reshaping Oncology


Share This Article



Summary

In this episode of "On the Edge of Breakthrough: Voices of Cancer Research," host Dr. Monty Pal welcomes Dr. Lee Jones, Head of the Exercise Oncology Program in the Department of Medicine at City of Hope, to discuss how exercise science is helping reshape cancer treatment and care. Dr. Jones shares his journey from the UK to City of Hope, highlighting the challenges and breakthroughs in establishing exercise as a vital part of oncology research.  

In this episode of "On the Edge of Breakthrough: Voices of Cancer Research," host Dr. Monty Pal welcomes Dr. Lee Jones, Head of the Exercise Oncology Program in the Department of Medicine at City of Hope, to discuss how exercise science is helping reshape cancer treatment and care. Dr. Jones shares his journey from the UK to City of Hope, highlighting the challenges and breakthroughs in establishing exercise as a vital part of oncology research.  

He explains how the field of exercise oncology has taken lessons from NASA and their work to prepare astronauts going to and coming back from space to improve outcomes for cancer patients throughout their treatment journey. 

The episode explores how breast cancer studies lay the groundwork for integrating exercise into survivorship and treatment and they dive into landmark trials, such as the CHALLENGE study, which showed exercise can improve survival for colorectal cancer patients. Dr. Jones emphasizes the need for rigorous, drug-like trial designs to truly measure the impact of exercise interventions. He argues innovative approaches such as decentralized trials, using remote monitoring and home-based exercise equipment are critical to expand access and collect real-time data. 

Dr. Jones shares a sneak peak of new studies launching in prostate cancer, high-risk populations, and collaborations with national research networks. His vision is to move beyond a cancer-cell focus, embracing holistic intervention s that consider the patient’s physiology and environment. 

Tune in to hear how City of Hope is pushing the boundaries of cancer research and care. 

Click for Source

Related Topics

Meet Our Innovation Partners

Loading partners...

You May Also Like

Podcast
What it Takes to Close the Gap in Pediatric Cancer Care with Leo Wang, M.D., Ph.D.
Partner Avatar Monty Pal

What it Takes to Close the Gap in Pediatric Cancer Care with Leo Wang, M.D., Ph.D.

Podcast
Reengineering CAR T for Solid Tumors: What Glioblastoma Has Taught Us with Christine Brown, Ph.D.
Partner Avatar Monty Pal

Reengineering CAR T for Solid Tumors: What Glioblastoma Has Taught Us with Christine Brown, Ph.D.

Article
Leveraging existing data to contextualize phase II clinical trial findings in oncology
OVN Avatar E.M. Ray, L.A. Carey, K.E. Reeder-Hayes

Leveraging existing data to contextualize phase II clinical trial findings in oncology

Podcast
Patient Education for Next-Generation Sequencing to Guide Cancer Therapy
OVN Avatar The Oncology Nursing Podcast

Patient Education for Next-Generation Sequencing to Guide Cancer Therapy

Article
Developing a framework to incorporate real-world evidence in cancer drug funding decisions: the Canadian Real-world Evidence for Value of Cancer Drugs (CanREValue) collaboration
OVN Avatar Kelvin Chan, Seungree Nam, Bill Evans, Claire de Oliveira Alexandra Chambers, Scott Gavura, Jeffrey Hoch, Rebecca E Mercer, Wei Fang Dai, Jaclyn Beca, Mina Tadrous, Wanrudee Isaranuwatchai

Developing a framework to incorporate real-world evidence in cancer drug funding decisions: the Canadian Real-world Evidence for Value of Cancer Drugs (CanREValue) collaboration

Article
Value assessment of oncology drugs using a weighted criterion-based approach
OVN Avatar Doreen A. Ezeife MD, Francois Dionne PhD, Aline Fusco Fares MD, Ellen Laura Rose Cusano MD, Rouhi Fazelzad BSc, MISt, Wenzie Ng BSc, MPharm, RPh, Don Husereau BSc Pharm, MSc, Farzad Ali BPharm, MSc, Christina Sit MSc, Barry Stein B.Com BCL, LLB, Jennifer

Value assessment of oncology drugs using a weighted criterion-based approach

Explore OVN